Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas L Feinstein

Showing results (1-10 of 145) with videos related to

Pageof 15
Sort By:
ASN Neuro|September 9, 2024
EditorialDouglas L Feinstein
Nature Neuroscience|March 6, 2023
Elena Galea (1962-2023)Douglas L Feinstein
Diabetes Technology & Therapeutics|May 3, 2003
Therapeutic potential of peroxisome proliferator-activated receptor agonists for neurological diseaseDouglas L Feinstein
Neuroscience Letters|September 25, 2023
Astrocyte lipocalin-2 modestly effects disease severity in a mouse model of multiple sclerosis while reducing mature oligodendrocyte protein and mRNA expressionSergey Kalinin, Douglas L Feinstein
Brain Research|December 25, 2017
The locus coeruleus neuroprotective drug vindeburnol normalizes behavior in the 5xFAD transgenic mouse model of Alzheimer's diseaseDavid Braun, Douglas L Feinstein
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|October 3, 2018
Comment on: Pesticide-Poisoned Patients: Can They Be Used as Potential Organ Donors?Israel Rubinstein, Douglas L Feinstein
Journal of Neuroimmunology|May 28, 2018
Influence of diet on axonal damage in the EAE mouse model of multiple sclerosisJeffrey L Dupree, Douglas L Feinstein
Advances in Pharmacology (San Diego, Calif.)|July 31, 2012
Altering mitochondrial dysfunction as an approach to treating Alzheimer's diseaseJerry R Colca, Douglas L Feinstein
ASN Neuro|October 19, 2020
History of Neuroscience I. Pío del Río-Hortega (1882-1945): The Discoverer of Microglia and OligodendrogliaAnne I Boullerne, Douglas L Feinstein
Journal of Neuroinflammation|April 1, 2016
Glial cell biology in the Great Lakes regionDouglas L Feinstein, Robert P Skoff
Pageof 15

Showing results (1-10 of 145) with videos related to

Sort By:
Pageof 15
ASN Neuro|September 9, 2024
EditorialDouglas L Feinstein
Nature Neuroscience|March 6, 2023
Elena Galea (1962-2023)Douglas L Feinstein
Diabetes Technology & Therapeutics|May 3, 2003
Therapeutic potential of peroxisome proliferator-activated receptor agonists for neurological diseaseDouglas L Feinstein
Neuroscience Letters|September 25, 2023
Astrocyte lipocalin-2 modestly effects disease severity in a mouse model of multiple sclerosis while reducing mature oligodendrocyte protein and mRNA expressionSergey Kalinin, Douglas L Feinstein
Brain Research|December 25, 2017
The locus coeruleus neuroprotective drug vindeburnol normalizes behavior in the 5xFAD transgenic mouse model of Alzheimer's diseaseDavid Braun, Douglas L Feinstein
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|October 3, 2018
Comment on: Pesticide-Poisoned Patients: Can They Be Used as Potential Organ Donors?Israel Rubinstein, Douglas L Feinstein
Journal of Neuroimmunology|May 28, 2018
Influence of diet on axonal damage in the EAE mouse model of multiple sclerosisJeffrey L Dupree, Douglas L Feinstein
Advances in Pharmacology (San Diego, Calif.)|July 31, 2012
Altering mitochondrial dysfunction as an approach to treating Alzheimer's diseaseJerry R Colca, Douglas L Feinstein
ASN Neuro|October 19, 2020
History of Neuroscience I. Pío del Río-Hortega (1882-1945): The Discoverer of Microglia and OligodendrogliaAnne I Boullerne, Douglas L Feinstein
Journal of Neuroinflammation|April 1, 2016
Glial cell biology in the Great Lakes regionDouglas L Feinstein, Robert P Skoff
Pageof 15